Regulatory RNAs – Comprehensive Study Notes
Overview & Historical Context
- Jacob & Monod (Nobel 1965) demonstrated that gene expression is controlled by dedicated regulatory elements; originally considered both proteins and RNAs.
- Early plant example: Petunia over-expression of a second chalcone-synthase gene caused complete loss of violet pigment → first hint of RNA-triggered "gene silencing".
- C. elegans RNAi discovery: injecting/feeding double-stranded RNA (dsRNA) switches specific genes OFF.
- Leukemia model: over-expression of a single microRNA in mouse immune cells transforms normal liver tissue → illustrates oncogenic potential of small RNAs.
Coding vs Non-Coding RNAs
- Coding RNAs: mRNAs.
- Non-coding RNAs (ncRNAs) fulfill other tasks:
• rRNA & tRNA – translation machinery.
• snRNA – splicing.
• gRNA – mitochondrial RNA editing.
• 7SL RNA – co-translational ER targeting.
• Small regulatory RNAs – focus of this lecture.
Length Benchmarks
- Bacterial sRNAs: .
- 6S RNA (E. coli): .
- Typical mi/siRNAs: guide strand produced from hairpins or long dsRNA.
- Drosha measures basal stem; Dicer measures upper stem.
Regulatory RNAs in Bacteria
trans-acting elements
• 6S RNA
– Binds RNA polymerase holo-enzyme, mimics open promoter DNA.
– Accumulates in stationary phase → shuts down dependent promoters; release upon nutritional up-shift when NTPs trigger 6S-templated "pRNA" synthesis → structural change → complex dissociates.
• sRNAs (small RNAs)
– No processing; immediately active.
– Need RNA-chaperone Hfq to stabilize RNA–RNA interactions.
– Two major functions:
▪ Translation control at Ribosome Binding Site (RBS).
• Activator mode: sRNA binds mRNA upstream sequestration region → exposes RBS.
• Repressor mode: sRNA base-pairs over RBS → masks it.
▪ RNA stability control together with RNase E (e.g., RyhB controls iron metabolism; OxyS during oxidative stress).cis-acting elements
• Riboswitches
– Located in the 5′ UTR of the same mRNA they regulate.
– Consist of an Aptamer (ligand-binding) + Expression Platform (structural switch).
– Ligands: purines (guanine, adenine), SAM, FMN, vitamin B$_{12}$, thiamine-PP, etc.
– Outcomes:
▪ Translation ON/OFF by exposing or hiding RBS (SAM example).
▪ Premature transcription termination by forming intrinsic terminator hairpin (guanine riboswitch, SAM-I/II).
– Energetically economical – no protein synthesis required; viewed as relic of an "RNA world".
• Attenuation
– Leader peptides containing multiple codons of the product amino acid (e.g., Trp). Ribosome speed senses charged-tRNA availability.
– Two mutually exclusive RNA structures: Terminator (regions 3–4) vs Anti-terminator (regions 2–3).
– High amino acid → fast ribosome → terminator forms → transcription halts.
– Low amino acid → stalled ribosome → anti-terminator → operon transcribed.
– Provides fine-tuning; main on/off switch still provided by repressor proteins.
Regulatory RNAs in Eukaryotes
RNA Interference (RNAi)
• Core concept: small RNAs guide Argonaut proteins to complementary RNA targets.
• Consequences
– Perfect/near-perfect match → Argonaut RNase ("Slicer") cleaves mRNA.
– Partial match → translational repression, poly(A) shortening, localization to P-bodies.
– Some organisms (plants, worms, fungi) use RNA-dependent RNA polymerase (RdRP) to amplify the signal, generating secondary siRNAs.Classes
• siRNA – processed from long exogenous or endogenous dsRNA by Dicer.
• miRNA – encoded in the genome, transcribed as primary miRNA (pri-miRNA); folded hairpins processed by Drosha → pre-miRNA, exported to cytoplasm → Dicer → mature duplex.Biogenesis details
• Microprocessor (Drosha + DGCR8/Pasha) in nucleus performs "Cropping"; leaves .
• Exportin-5 transports pre-miRNA.
• Cytoplasmic Dicer "Dicing" creates duplex; PAZ domain grips 3′ overhang, RNase III domains cut.
• Duplex loading into Argonaut; passenger strand discarded, guide strand retained.RISC vs RITS
• RISC (RNA-Induced Silencing Complex) – cytoplasmic, post-transcriptional gene silencing.
• RITS (RNA-Induced Transcriptional Silencing) – nuclear, recruits histone methyltransferase Clr4, HP1 homolog Swi6 → H3K9me heterochromatin (shown in S. pombe centromeres).
Disease Connections & Examples
- Cancer
• miR-15a / miR-16-1 normally repress BCL-2; deletion → chronic lymphocytic leukemia.
• let-7 family targets RAS oncogene; down-regulation increases RAS.
• miR-17–92 cluster over-expressed → oncogenic; targets tumor suppressors PTEN, RB2. - Therapeutic/diagnostic companies: Asuragen, Crogen Pharmaceuticals, Miragen, Regulus, Rosetta Genomics explore miRNA-based products (cancer, cardiovascular, viral diseases).
Key Protein Machines
- Dicer – length-measuring RNase III; PAZ domain (binds 3′ overhang), RNase III A & B cut both strands → $\text{\sim22 nt} products.
- Drosha – nuclear RNase III; defines pre-miRNA hairpin base with DGCR8.
- Argonaut – endonuclease (PIWI domain) + PAZ; binds 5′ phosphate of guide RNA.
- Hfq – bacterial hexameric chaperone, RNA annealing facilitator.
Chromosome-Scale Regulation: X-Inactivation (Mammals)
- Females (XX) equalize gene dosage with males (XY) by inactivating one X.
- X-inactivation center (Xic) encodes:
• Xist RNA – coats its own chromosome in cis; recruits chromatin silencing machinery → hypoacetylation, H3K27me3, DNA methylation.
• Tsix RNA – antisense to Xist; represses Xist on the active X. - Choice is random at cell stage → females are mosaics (e.g., tortoiseshell cats with black/orange patches).
Evolutionary Perspective
- RNAi assumed ancient immune system against mobile genetic elements & viruses.
• Up to of human genome = transposon remnants; often packaged in heterochromatin via RNAi.
• Budding yeast (S. cerevisiae) lost RNAi; fission yeast (S. pombe) retained it (centromere silencing) but lacks canonical miRNAs. - Fungi Neurospora crassa
• Quelling – vegetative RNAi of duplicated DNA.
• RIP – repeat-induced point mutation during sexual cycle.
• MSUD – meiotic silencing by unpaired DNA. - Dosage compensation strategies: mammals inactivate one X; Drosophila up-regulates male X via different ncRNAs.
Industrial & Clinical Applications
- Diagnostic signatures: circulating miRNAs as non-invasive cancer biomarkers.
- Therapeutics: antagomiRs (miRNA inhibitors), miRNA mimics, siRNA drugs (e.g., for viral infections, hypercholesterolemia).
Conceptual Connections & Take-Home Messages
- Regulatory RNAs provide multilayered control: transcriptional, post-transcriptional, translational, chromatin.
- They act faster and more economically than protein regulators, can form complex networks (one miRNA targets many mRNAs & vice versa).
- Many mechanisms (riboswitches, attenuation) illustrate RNA’s pre-protein regulatory potential, supporting the RNA-world hypothesis.